Merck, a leading science and technology company, is reinforcing the importance of early detection by introducing an online educational Symptom Checker designed to help individuals recognise potential warning signs and prompt timely medical consultation.
Colorectal cancer (CRC) remains one of the most common cancers in the Gulf. When detected early, it is highly treatable. However, many cases continue to be diagnosed at later stages, highlighting the need for greater awareness, routine screening, and earlier action.
Ahmed Fadl, General Manager – Gulf, Merck said: “Colorectal cancer outcomes can improve significantly when the disease is identified early. Raising awareness of common symptoms and encouraging people to seek medical advice without delay is critical. This educational tool is designed to support that first step, helping individuals recognise potential warning signs and initiate informed conversations with their healthcare professionals.”
Colorectal cancer symptoms are often non-specific and may be associated with other conditions. The Symptom Checker is a short, user-friendly questionnaire that asks about signs such as changes in bowel habits, blood in stool, unexplained weight loss, persistent abdominal discomfort, fatigue, and family history.
The tool is intended as an educational resource only and does not provide a medical diagnosis. Where responses indicate potential risk, users are encouraged to consult a healthcare professional and discuss appropriate screening options, including stool-based testing or colonoscopy.
| Colorectal Cancer in the Gulf: Regional Snapshot | |
| United Arab Emirates | CRC is among the most common cancers in the UAE where 41% of diagnosed cases are among individuals under the age of 40 |
| Oman | CRC is one of the most frequently diagnosed cancers among men and the second leading cause of cancer-related mortality overall. |
| Kuwait | CRC is the second most common cancer after breast cancer. Data from the Kuwait Cancer Registry shows that between January 2010 and December 2019, there were 2,710 cases of CRC, accounting for approximately 10.2% of all cancer cases in the country. |
| Qatar | According to data from the World Health Organization’s International Agency for Research on Cancer (IARC), in 2022 CRC was the second most commonly diagnosed cancer (11.1%) among men and the third most commonly diagnosed cancer (9.5%) among women. |
| Bahrain | World Health Organization’s International Agency for Research on Cancer (IARC) estimates show that in 2022 CRC emerged as the most commonly diagnosed cancer among men in the Kingdom of Bahrain, with an incidence rate of 14.8%. |
Regular screening remains one of the most effective methods of early detection. Adults aged 50 and above are at increased risk, and routine screening can identify precancerous changes before cancer develops.
